Caregen Co., Ltd. (KOSDAQ:214370)
South Korea
· Delayed Price · Currency is KRW 106,000
-1,000 (-0.93%)
Apr 29, 2026, 3:30 PM KST
Caregen Revenue
In the year 2025, Caregen had annual revenue of 72.81B KRW, down -11.84%. Caregen had revenue of 16.31B in the quarter ending December 31, 2025, a decrease of -23.64%.
Revenue
72.81B
Revenue Growth
-11.84%
P/S Ratio
71.15
Revenue / Employee
377.24M
Employees
193
Market Cap
5,180.30B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 72.81B | -9.78B | -11.84% |
| Dec 31, 2024 | 82.59B | 3.38B | 4.26% |
| Dec 31, 2023 | 79.21B | 10.11B | 14.63% |
| Dec 31, 2022 | 69.10B | 10.01B | 16.94% |
| Dec 31, 2021 | 59.09B | -1.21B | -2.00% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| KCC Corporation | 6,483.82B |
| Lotte Chemical | 18.48T |
| Soulbrain | 923.38B |
| ISU Specialty Chemical | 376.10B |
| Hansol Chemical | 883.97B |
| Kolon Industries | 4,873.40B |
| Dongjin Semichem | 1,194.14B |
| Hankuk Carbon | 908.81B |
Caregen News
- 1 year ago - Akums Drugs shares surge 5% after signing Master Sales Agreement with Caregen - Business Upturn
- 1 year ago - Akums Drugs signs Master Sales Agreement with Caregen for Indian Nutraceutical market expansion - Business Upturn